← Evidence map

ArticleTranslational andrology and urology2019

A new strategy for the treatment of sorafenib-refractory metastatic renal cell carcinoma in China: combination with intermittent chemotherapy.

Zicheng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2019
2020
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31555557